This research demonstrates the role of SDR12 in xenobiotic metabolism in Haemonchus contortus, suggesting implications for drug resistance.
Abstract Short-chain dehydrogenases/reductases (SDRs) play a crucial role in xenobiotic and eobiotic metabolism in all organisms. In the parasitic nematode Haemonchus contortus, SDRs represent potential contributors to drug resistance and potential drug targets. Among them, Hco_sdr12 (WormBaseAcc: HCON_0049110) seemed to be the most interesting as its constitutive expression was higher in all developmental stages of H. contortus from the drug-resistant strain in comparison to the drug-susceptible strain. Moreover, Hco_sdr12 was inducible by exposure of H. contortus adult males with the anthelmintic drug flubendazole. With an aim to know more about this enzyme, Hco_SDR12 (UniprotAcc: A0A7I5E7J1) was cloned, purified and characterised. The corresponding gene was cloned into the pET22b(+) vector system, the protein was overexpressed in E. coli and purified by Ni-affinity chromatography. The various xenobiotic and eobiotic compounds, including flubendazole, were tested as potential substrates of Hco_SDR12. Although this enzyme did not reduce flubendazole, significant reductase activities toward many other substrates were found with a preference for NADPH as a coenzyme. Glyceraldehyde, metyrapone and ketoprofen were used for kinetic studies. According to bioinformatic analysis, Hco_SDR12 shares the highest similarity with hydroxysteroid dehydrogenase-like protein 2, which indicates its involvement in lipid metabolism. Even though Hco_SDR12 cannot deactivate flubendazole, it can deactivate other xenobiotics with a carbonyl group. Its higher expression might help nematodes to protect themselves against reactive compounds and to gain energy from lipides more effectively.
No takes yet. Share an insight, caveat, or question.
Rychlá et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: